Regenx® Medical Institute Expanding to Provide Better Hormone Replacement Therapy that can Protect Against Cancer

Regenx® Medical Institute, a leading provider of customized Hormone Replacement Therapy (HRT) programs, is reacting to new studies on the benefits of HRT for men and women and the importance of medically supervised therapies versus self-medications.

Bay Harbor, Miami, FL (PRWEB) March 16, 2012

Regenx® Medical Institute is starting a nationwide campaign to bring the benefits of modern Hormone Replacement Therapy (HRT) to men and women with hormone deficiencies relating to menopause and andropause. (http://www.regenxmd.com)

A new landmark study from March 2012 has shown that certain estrogen replacement therapies after menopause protects against breast cancer even long after treatment is stopped. These therapies are design to fight the very common symptoms of female hormone imbalance such as hot flashes, vaginal dryness, lower sex drive and a general feeling of fatigue.

The study came from the Women's Health Initiative (WHI), a large US study of post-menopausal women launched in 1993. The results showed that women who had estrogen HRT for seven years were 20 percent less likely to develop breast cancer compared to a control group that only received placebo treatment. This positive effect also lasted for more than five years after the therapy ended.
Doctors emphasized that the benefit had to be balanced against stroke and blood clot risks that resulted from Hormone Replacement Therapy. They recommended taking hormones at the lowest dose possible and balancing the medication with regards to the exact requirements of each patient.

To put these new scientific findings into effect Regenx® Medical Institute is expanding its efforts to provide completely customized, personalized and individualized HRT treatments that take the specific medical background of each client into account. Each patient is carefully examined and evaluated via the following methods:

• A Detailed Blood Panel
• Complete Physical
• Full Medical History Profile

This allows the medical team and life coaches of Regenx® Medical Institute to coordinate and implement scientific HRT programs that maximize the positive effect on menopause symptoms and cancer protection while minimizing side effects.

Regenx® Medical Institute only administers Hormone Replacement Therapies to those who have actual hormonal deficiencies with the stated goal of bringing the body back into balance. The team is comprised of several medical and functional medicine doctors and life coaches who oversee all aspects of hormone treatment and FDA approved drug administration.

Treatments are also available to men using testosterone to reverse the decline of the hormone, or so-called andropause, the male counterpart to female Menopause. Generally, men reach their physical peak at the age of 17. By the time they pass the age of 30, testosterone levels may be 50% lower.

Scientists agree that it's especially important to make sure the program is medically supervised by doctors and healthcare professionals instead of starting any self-medication with hormone-like products sold over the counter without prescription. These products are not FDA approved and may have serious health consequences.
Medical doctors attached to the Regenx® Medical Institute HRT clinic will first examine each patient before administering hormone treatment. This is a safe, scientific and highly rewarding path to managing the aging process.

For additional information on the Regenx® Medical Institute or Hormone Replacement Therapies, call 888-9 REGENX (1-888-973-4369) or visit http://www.regenxmd.com.
Regenx® Medical Institute is a turnkey medically supervised Hormone Replacement Therapy (HRT) program focused on early detection of aging deficiencies before they become health issues.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/3/prweb9289381.htm